Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 204 participants.

Also called NCT01555658

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Phase 3
Enrolled
  • 204 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01555658
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01555658. Randomized; no masking; primary purpose prevention. Start 2012-04 (registry gives no type); primary completion 2012-09 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Bivalirudin Plus Stenting in Long Lesion to Avoid Periprocedural Myocardial Necrosis Trial
Acronym
BILLION
Intervention (Drug)
Bivalirudin
Intervention (Drug)
Unfractioned Heparin
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01555658
Content hash
85cc818c7297c962079a02f067fb590886a090988f3f48d90e8ac8d266d37e05